Addition of proton pump inhibitor to treatment of poorly controlled asthma in children does not improve symptoms

Children without symptoms of gastroesophageal reflux whose asthma was being poorly controlled with anti-inflammatory treatment did not have an improvement in symptoms or lung function with the added treatment of the proton pump inhibitor lansoprazole, compared to patients who received placebo, according to a new study. Use of lansoprazole was associated with increased adverse events.